Many adults have features of both asthma and COPD. This is described as asthma–COPD overlap, which is now recognised as an important clinical problem. This information paper is intended to provide information on the diagnosis and treatment of asthma–COPD overlap for GPs, asthma educators, practice nurses and pharmacists.
This information paper was prepared in consultation with the following health professionals:
Developed in partnership with Lung Foundation Australia.
Funded by a grant from AstraZeneca. Apart from providing a financial grant, AstraZeneca has not been involved in the development, recommendation, review or editing of this publication.
National Asthma Council Australia & Lung Foundation Australia. Asthma–COPD overlap. Melbourne: National Asthma Council Australia, 2017.
Printed copies of our resources, including this information paper and patient brochure, can be ordered through our online order system.
Although all care has been taken, this information paper is only a general guide; it is not a substitute for assessment of appropriate courses of treatment on a case-by-case basis. The National Asthma Council Australia expressly disclaims all responsibility (including negligence) for any loss, damage or personal injury resulting from reliance on the information contained herein.
Latest evidence on the prevalence and impact of incorrect technique, plus checklists for using each inhaler correctly